Veterinary Medicines

Parvoruvax Suspensie voor injectie

Authorised
  • Porcine parvovirus, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
Download as PDF

Product identification

Medicine name:
Parvoruvax Suspensie voor injectie
Parvoruvax Suspension injectable
Parvoruvax Injektionslösung
Active substance:
  • Porcine parvovirus, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Porcine parvovirus, Inactivated
    2.00
    haemagglutination inhibiting unit(s)
    /
    2.00
    millilitre(s)
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
    1.00
    enzyme-linked immunosorbent assay unit
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • All relevant tissues
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Parvoruvax 1 Vial with 25 doses (50 ml) of Suspension for injection
  • Parvoruvax 1 Vial with 5 doses (10 ml) of Suspension for injection
  • Parvoruvax 1 Vial with 50 doses (100 ml) of Suspension for injection

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva-Phylaxia Veterinary Biologicals Co. Ltd.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 7/03/2023
Download
French (PDF)
Published on: 7/03/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 7/03/2023
Download
French (PDF)
Published on: 7/03/2023
Download
German (PDF)
Published on: 7/03/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."